上市公司資料
 
凱萊英醫藥集團(天津)股份有限公司 股票代號:  06821
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. 集團網址: http://www.asymchem.com
損益表
  2024/12
RMB(K$)
變動 2023/12
RMB(K$)
2022/12
RMB(K$)
營業額5,804,657-25.404%7,781,43610,230,186
經營溢利/(虧損)1,047,521-59.070%2,559,2993,691,893
特殊項目--------
攤佔聯營公司及共同控制公司溢利/(虧損)24,860--(2,169)33,052
稅前溢利/(虧損)1,072,381-58.063%2,557,1303,724,945
稅項(136,625)--(306,310)(430,314)
少數股東權益13,194-26.663%17,9917,004
股東應佔溢利/(虧損)948,950-58.174%2,268,8113,301,635
 
淨利息收入/(支出)200,89630.261%154,22666,096
折舊與攤銷526,1308.066%486,859361,977
董事酬金----30,77228,273
 
每股盈利/(虧損)(仙)269.000-57.029%626.000902.000
每股派息(仙)110.000-38.889%180.000180.000
 
派息比率(%)40.892%--28.754%19.956%
每股帳面資產淨值($)47.4680.384%47.28742.292
主要財務比率
  2024/12
RMB(K$)
變動 2023/12
RMB(K$)
2022/12
RMB(K$)
經營邊際利潤率(%)18.046%--32.890%36.088%
利息盈利率(x)113.823--433.532354.780
資產回報率(%)4.859%--11.939%19.773%
股東資金回報率(%)5.529%--13.698%23.368%

 

Copyright © 2025 ET Net Limited. All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.